Status:
NOT_YET_RECRUITING
Interleukin-4 in Pityriasis Lichenoides Chronica
Lead Sponsor:
Cairo University
Conditions:
Pityriasis Lichenoides
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
assessment of the level of interleukin 4 (IL-4) in the lesional skin and serum of PLC patients and compare its level with healthy controls.
Detailed Description
measuring the level of Interleukin 4 in lesional skin and it's serum level using ELIZA in patients with Pityriasis lichenoides chronica and comparing the levels with healthy controls levels
Eligibility Criteria
Inclusion
- Patients with pityriasis lichenoides Chronica (PLC): either with the classical presentation papular or hypo-pigmented macules and patches that proved histopathologically to be PLC.
- Both genders
- Age group ≥ 8 years
Exclusion
- Patients with other skin diseases
- Patient received treatment for PLC within period less than three months
- Pregnant patients
- Lactating patients
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06889506
Start Date
April 1 2025
End Date
July 1 2025
Last Update
March 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.